Navigation Links
Basic research leads to a novel cancer therapy

cancer development. The Max Planck scientists showed that tumour tissue just a few cubic millimetres in size can create vascular endothelial growth factor (VEGF), which triggers blood vessel development.

Ullrich found some of the most important evidence in research on animals, conducted with colleagues Birgit Millauer and the late Werner Risau, formerly of the Max Planck Institute of Neurobiology. There is a receptor specific to VEGF, called Flk-1/VEGFR2, found only in endothelial cells which are the building stones of new blood vessels. When Flk-1/VEGFR2 is made inoperative, this blocks the development of tumours. If no blood vessels are created in tumour tissue, the tumour fails to grow. This discovery led to the invention of what are called angiogenesis inhibitors (angiogenesis is the process of blood vessel formation).

Ullrich and the Max Planck Society, in co-operation with New York University, founded SUGEN, Inc. in California in 1991. SUGEN is the first biotechnology company with roots in the Max Planck Society. The firm developed chemical substances which block Flk-1/VEGFR2 in endothelial cells. At the end of the 1990s SUGEN was taken over by Pharmacia, which itself was bought by Pfizer in 2003. Development of the project continued at Pfizer. SUTENT® (active ingredient Sunitinib) has now reached the market as a multi-targeted tyrosine kinase inhibitor, which blocks both the building of blood vessels in tumours as well as other illness-related enzymes in tumour cell signalling networks.

Clinical studies with GIST patients looked into their ability to tolerate Sunitinib, as well as its effectiveness on them. Some of these patients had already been treated with Imatinib, but their tumours continued to develop. Others were not able to tolerate Imatinib at all. Still other patients had advanced renal cell carcinoma with failed available treatment. In the case of the GIST patients, it took four times longer for tumours to renew growth when
'"/>

Source:Max-Planck-Gesellschaft


Page: 1 2 3 4

Related biology news :

1. Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST)
2. Basic work on E. coli identifies two new keys to regulation of bacterial gene expression
3. Columbia research lifts major hurdle to gene therapy for cancer
4. U of M researcher examines newly emerging deadly disease
5. NYU researchers simulate molecular biological clock
6. First atlas of key brain genes could speed research on cancer, neurological diseases
7. New research questions basic tenet of neuron function
8. Vital step in cellular migration described by UCSD medical researchers
9. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
10. UCSD researchers maintain stem cells without contaminated animal feeder layers
11. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Basic research leads novel cancer therapy

(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... the atomic structure of a powerful "molecular motor" that ... during their assembly, an essential step in their ability ... researchers, from Purdue University and The Catholic University of ... motor works. Parts of the motor move in sequence ...
... Scientists have identified an initiating molecular mechanism in ... Cell Press in the December 26th issue of ... about generation of damaging amyloid β (Aβ) plaques ... of developing new preventative and disease-modifying therapies for ...
... that the human brainonce thought to be a seriously ... make the best decisions possible with the information we ... of the journal Neuron ., Neuroscientists Daniel Kahneman ... their 1979 research that argued humans rarely make rational ...
Cached Biology News:Biologists learn structure, mechanism of powerful 'molecular motor' in virus 2Biologists learn structure, mechanism of powerful 'molecular motor' in virus 3Impaired energy metabolism linked with initiation of plaques in Alzheimer's brain 2Our unconscious brain makes the best decisions possible 2Our unconscious brain makes the best decisions possible 3
(Date:6/1/2015)... BAY HEAD, N.J. , June 1, 2015 /PRNewswire/ ... to launch a national innovative science curriculum for high ... announcement at the 16 th annual LIFE Event ... held at Mountain Ridge Country Club in ... some of the LPGA,s biggest stars raised more than ...
(Date:6/1/2015)... 2015  Boston-based Veritas Genetics is launching its ... bring personalized medicine and prevention to the forefront, ... health. Beginning with its first product, a genetic ... Veritas Genetics is making its products affordable and ... of genetic data which will be shared with ...
(Date:6/1/2015)... - Resverlogix Corp. (TSX: RVX) (the "Company") today announced ... ERA-EDTA Congress in London, England ... Epigenetic BET-Inhibitor, on Key Renal Parameters in Subjects with ... a Post-hoc Analysis of Patients from the ASSERT, SUSTAIN ... Kam Kalantar-Zadeh , Professor and Chief, Division of Nephrology and Hypertension at ...
(Date:6/1/2015)... DUBLIN , May 29, 2015 /PRNewswire/ ... has announced the addition of the ... Market" report to their offering. ... of the European immunoprotein diagnostic market, including ... shares, and strategic profiles of leading suppliers. ...
Breaking Biology Technology:Val Skinner Foundation Announces Partnership With Discovery Education 2Veritas Genetics To Advance Precision Medicine And Disease Prevention 2Veritas Genetics To Advance Precision Medicine And Disease Prevention 3Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 2Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 3Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 4
... cases from across the country to advance cancer care ... Inc ., the innovative healthcare company supporting the ... recognized as a Laureate by the International ... Program for its interactive patient management software ...
... Bulletin Board: RNER; "the Company"), which recently changed its ... new symbol to better reflect,its business. The new symbol: ... NASDAQ. , "The Company intends ... manufacturing business in China. The Company has,launched a new ...
... Infarction provided jointly by leading international cardiology societiesTOKYO ... Phase III TRITON-TIMI 38 study applied the new ... Infarction to the results of the study and ... undergoing percutaneous coronary intervention (PCI) and taking prasugrel, ...
Cached Biology Technology:US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 2US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 3US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 4US Oncology Named 2009 Laureate by IDG Computerworld Honors Program 5RainEarth Inc. Changes Trading Symbol from GRKR to RNER 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6
...
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature....
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
... Amplification Grade digests single- ... oligodeoxyribonucleotides. The specific activity ... I Amplification Grade is ... for absence of RNase ...
Biology Products: